lobbying_activities: 3801559

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3801559	badf764f-0ac9-4169-ae94-d5dfbbf4e161	Q1	MCDERMOTT+ LLC	401103287	PATIENTS FOR AFFORDABLE DRUGS NOW	2026	first_quarter	MMM	Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2026-04-01T10:10:57-04:00